Eligibility for<sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of<sup>68</sup>Ga-PSMA-11 and<sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
The Journal of nuclear medicine